You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
Baxter
McKesson
Colorcon
Johnson and Johnson
AstraZeneca

Last Updated: May 17, 2021

DrugPatentWatch Database Preview

Litigation Details for Purdue Pharma L.P. v. PAR Pharmaceutical, Inc. (S.D.N.Y. 2011)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Purdue Pharma L.P. v. PAR Pharmaceutical, Inc.
The small molecule drug covered by the patents cited in this case is   Get Started Free .

Details for Purdue Pharma L.P. v. PAR Pharmaceutical, Inc. (S.D.N.Y. 2011)

Date Filed Document No. Description Snippet Link To Document
2011-03-23 1 United States Patent No. 7,776,314 entitled “ABUSE-PROOFED DOSAGE SYSTEM” (“the ‘314 patent”), including…and an exclusive licensee of United States Patent No. 7,776,314 identified in paragraph 18 below, Purdue…Griinenthal is the owner of United States Patent No. 7,776,314 identified in paragraph 18 below. THE PARTIES…the ‘314 patent from Griinenthal, with the right to enforce the ‘314 patent. The ‘314 patent is listed…ACTION l. This is an action for patent infringement arising under the patent laws of the United States, Title External link to document
2013-09-10 116 invention date for the claims of U.S. Patent No. 6,488,963 Patent that is earlier than June 26, 1996; 2… 2. Plaintiffs stipulate that European Patent Application 0 661 045 ("the EP '045 Publication") was published…1995, and is prior art to the claims of the '963 Patent under 35 U.S.C. § 102(a); 3. and Plaintiffs will…the EP '045 Publication is prior art to the '963 Patent at trial. (Signed by Judge Sidney H. Stein on 9… 24 September 2013 1:11-cv-02038 830 Patent None District Court, S.D. New External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
Baxter
Express Scripts
Merck
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.